Novel methodology for antiretroviral quantitation in the female genital tract

HIV Clinical Trials

Volumn 10, Issue 3, 2009, Pages 193-199

  Bennetto Hood, Chantelle ^a   Johnson, Victoria A ^b,c   King, Jennifer R ^a   Hoesley, Craig J ^c   Acosta, Edward P ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

Antiretroviral; Drug monitoring; Women

Indexed keywords

ATAZANAVIR; LOPINAVIR; NEVIRAPINE; RITONAVIR; TENOFOVIR;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC KIT; DRUG PENETRATION; DRUG TISSUE LEVEL; EXTRACTION; FEMALE; FEMALE GENITAL SYSTEM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; LOW TEMPERATURE; MASS SPECTROMETRY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SPECTROPHOTOMETER; STORAGE TEMPERATURE; VAGINA SECRETION; VAGINAL LAVAGE;

ANTI-RETROVIRAL AGENTS; CERVIX UTERI; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; OLIGOPEPTIDES; PYRIDINES; PYRIMIDINONES; RITONAVIR; VAGINA; VAGINAL SMEARS;

EID: 69249090104     PISSN: 15284336     EISSN: None     Source Type: Journal    
DOI: 10.1310/hct1003-193     Document Type: Article

References (17)

1. Coombs RW, Speck CE, Hughes JP, et al. Association between cultureable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood. J Infect Dis. 1998;177: 320-330.
2. Garcia-Bujalance S, Ruiz G, Landron de Guevara C, et al. Quantitation of human immunodefi ciency virus type 1 RNA loads in cervicovaginal secretions in pregnant women and relationship between viral loads in the genital tract and blood. Eur J Clin Microbiol Infect Dis. 2004;23:111-115.
3. Hart CE, Lennox JL, Pratt-Palmore M, et al. Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract. J Infect Dis. 1999;179:871-882.
4. Kovacs A, Chan LS, Chen Z, et al. HIV-1 RNA in plasma and genital tract secretions in women infected with HIV-1. J Acquir Immune Defic Syndr. 1999;22:124-131.
5. Pilcher CD, Shugars DC, Fiscus SA, et al. HIV in body fl uids during primary HIV infection: implications for pathogenesis, treatment and public health. AIDS. 2001;15:837-845.
6. Shaheen F, Sison AV, McIntosh L, Mukhtar M, Pomerantz RJ. Analysis of HIV-1 in the cervicovaginal secretions and blood of pregnant and nonpregnant women. J Hum Virol. 1999;2:154-166.
7. Tachet A, Dulioust E, Salmon D, et al. Detection and quantification of HIV-1 in semen: identifi cation of a subpopulation of men at high potential risk of viral sexual transmission. AIDS. 1999;13:823-831.
8. Cu-Uvin S, Caliendo AM, Reinert S, et al. Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA. AIDS. 2000;14:415-421.
9. Debiaggi M, Zara F, Spinillo A, et al. Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy. Eur J Clin Microbiol Infect Dis. 2001;20:91-96.
10. Fiore JR, Suligoi B, Saracino A, et al. Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies. AIDS. 2003;17:2169-2176.
11. Taylor S, Pereira AS. Antiretroviral drug concentrations in the semen of HIV-1 infected men. Sex Transm Inf. 2001;77:4-11.
12. Si-Mohamed A, Kazatchkine MD, Heard I, et al. Selection of drug-resistant variants in the female genital tract of human immunodefi ciency virus type-1-infected women receiving antiretroviral therapy. J Infect Dis. 2000;182: 112-122.
13. Min SS, Corbett AH, Rezk N, et al. Protease inhibitor and nonnucleoside reverse transcriptase inhibitor concentrations in the genital tract of HIV-1-infected women. J Acquir Immune Defic Syndr. 2004;37:1577-1580.
14. Tribut O, Arvieux C, Michelet C, Chapplain JM, Allain H, Bentue-Ferrer D. Simultaneous quantitative assay of six HIV protease inhibitors, one metabolite, and two nonnucleoside reverse transcriptase inhibitors in human plasma by isocratic reversed-phase liquid chromatography. Ther Drug Monit. 2002;24:554-562.
15. Baron P, Bremer J, Wasserman SS, et al. Detection and quantitation of human immunodefi ciency virus type 1 in the female genital tract. The Division of AIDS Treatment Research Initiative 009 Study Group. J Clin Microbiol. 2000;38:3822-3824.
16. Hajjar AM, Lewis PF, Endeshaw Y, et al. Effi cient isolation of human immunodeficiency virus type 1 RNA from cervical swabs. J Clin Microbiol. 1998;36:2349-2352.
17. John GC, Sheppard H, Mbori-Ngacha D, et al. Comparison of techniques for HIV-1 RNA detection and quantitation in cervicovaginal secretions. J Acquir Immune Defic Syndr. 2001;26:170-175.